Title
NTM Info and Research Inc. – Nontuberculous Mycobacteria
Go Home
Category
Description
Address
Phone Number
+1 609-831-2326 (US) | Message me
Site Icon
NTM Info and Research Inc. – Nontuberculous Mycobacteria
Tags
Page Views
0
Share
Update Time
2022-06-16 01:30:08

"I love NTM Info and Research Inc. – Nontuberculous Mycobacteria"

www.ntminfo.org VS www.gqak.com

2022-06-16 01:30:08

About UsContact UsPamphlet PDF ▼EnglishEspañolPortugueseItalianFrançaisDeutschDutchChineseJapaneseKoreanVietnameseInternational Sites ▼AustraliaItalyLuxembourgUnited KingdomEnglishDeutsch日本語Online CommunityWhat Is NTM?Who Gets NTM?Common NTM Infection SymptomsHow Did I Get NTM?Am I Contagious?Why Have I Not Heard of It?BronchiectasisOther Related IllnessesCystic FibrosisAutoimmune pulmonary alveolar proteinosis (aPAP)How Is NTM Infection Diagnosed?PreventionReducing ExposureIndoor Air QualityAllergiesNTM & Other InfectionsLearn MoreLiving with NTMNTM Treatment : The Emphasis Is On YouFollow-Up: Keep Control of Your IllnessNutrition GuideMedication ScheduleTraveling TipsOther TipsQuality of Life IssuesTreatments and Side EffectsNTM Lung Disease TreatmentVisual AcuityAirway ClearanceSurgeryATS StatementSide Effects of NTM TreatmentNontuberculous Mycobacterial Infection EpidemiologyExtrapulmonary NTM InfectionHeater-Cooler Unit ExposureMedical Tourism & NTM InfectionsAirway Clearance TherapyYour Doctors & YouWhich Doctors?PulmonaryInfectious DiseasesRespiratory TherapistsDietitians & NutritionistsMental HealthInternal MedicineIntegrative MedicineQuestions to Ask Your DoctorInsurance Medicare TipsFamily Health HistoryPhysician Referral ListPhysician Referral ListCanadaAustraliaNicaraguaHow to use NTM ConnectThe Role of ReferralsGlossaryResourcesNewsCalendar“Insight” Patient PamphletUseful LinksIMPACT Educational ToolsSupport for NTM & Bronchiectasis PatientsLocal Support Groups For NTMand Bronchiectasis PatientsNTM Connect360SocialInfo LineStart a Support GroupNTM AustraliaVideosResearchOverviewClinical TrialsFunded ResearchNTM RegistryPublished ResearchGet InvolvedDonateOther Ways to GiveFundraising IdeasE-Mail SignupTake ActionAbout UsContact UsPamphlet PDF ▼EnglishEspañolPortugueseItalianFrançaisDeutschDutchChineseJapaneseKoreanVietnameseInternational Sites ▼AustraliaItalyLuxembourgUnited KingdomEnglishDeutsch日本語Online CommunityWhat Is NTM?Who Gets NTM?Common NTM Infection SymptomsHow Did I Get NTM?Am I Contagious?Why Have I Not Heard of It?BronchiectasisOther Related IllnessesCystic FibrosisAutoimmune pulmonary alveolar proteinosis (aPAP)How Is NTM Infection Diagnosed?PreventionReducing ExposureIndoor Air QualityAllergiesNTM & Other InfectionsLearn MoreLiving with NTMNTM Treatment : The Emphasis Is On YouFollow-Up: Keep Control of Your IllnessNutrition GuideMedication ScheduleTraveling TipsOther TipsQuality of Life IssuesTreatments and Side EffectsNTM Lung Disease TreatmentVisual AcuityAirway ClearanceSurgeryATS StatementSide Effects of NTM TreatmentNontuberculous Mycobacterial Infection EpidemiologyExtrapulmonary NTM InfectionHeater-Cooler Unit ExposureMedical Tourism & NTM InfectionsAirway Clearance TherapyYour Doctors & YouWhich Doctors?PulmonaryInfectious DiseasesRespiratory TherapistsDietitians & NutritionistsMental HealthInternal MedicineIntegrative MedicineQuestions to Ask Your DoctorInsurance Medicare TipsFamily Health HistoryPhysician Referral ListPhysician Referral ListCanadaAustraliaNicaraguaHow to use NTM ConnectThe Role of ReferralsGlossaryResourcesNewsCalendar“Insight” Patient PamphletUseful LinksIMPACT Educational ToolsSupport for NTM & Bronchiectasis PatientsLocal Support Groups For NTMand Bronchiectasis PatientsNTM Connect360SocialInfo LineStart a Support GroupNTM AustraliaVideosResearchOverviewClinical TrialsFunded ResearchNTM RegistryPublished ResearchGet InvolvedDonateOther Ways to GiveFundraising IdeasE-Mail SignupTake Action Donate NowAbout UsContact UsPamphlet PDF ▼EnglishEspañolPortugueseItalianFrançaisDeutschDutchChineseJapaneseKoreanVietnameseInternational Sites ▼AustraliaItalyLuxembourgUnited KingdomEnglishDeutsch日本語 Do you have Nontuberculous Mycobacterial (NTM) Pulmonary Disease? RECRUITING PATIENTS WITH NTM PULMONARY DISEASE CAUSED BY MYCOBACTERIUM ABSCESSUS COMPLEX (MABc) LEARN MORE #WISHFORCLEARLUNGS ONE BREATH BALLOON CHALLENGE Did you know that inflating a balloon is one way to help patients exercise their lungs?Help us blow up awareness on NTM and bronchiectasis lung disease. Learn More IMPORTANT ANNOUNCEMENT Currently there is a nationwide shortage of sodium chloride. This is impacting patients with bronchiectasis who perform twice daily airway clearance with hypertonic saline which is also known as sodium chloride. LEARN MORE learn more NTMir Youtube Watch our recordedwebinars Join the Phase 3 trial of CleaR-Mac – RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease CleaR-MAC) Join Clinical Trial ARISE/ENCORE Clinical Trial Program for MAC Lung Disease Read More NOW AVAILABLE "INSIGHT" A Patients Perspective Insight into the lung disease caused by nontuberculousmycobacteria (NTM), and empowers the patient to participate in his or her owntreatment. AVAILABLE IN VARIOUS LANGUAGES, REQUEST YOUR COPY TODAY. A Physician’s Perspective by Ed Chan, MD DOWNLOAD STAY INFORMED Click here to sign up for the latest news on NTMir SIGN UP NOW NEW RESEARCH OPPORTUNITY Now recruiting participants for an interview and questionnaire-only research study ofNTM MAC lung disease LEARN MORE JOIN NOW BRONCHIECTASIS PATIENTS SUPPORT FOR NTM & WHO WE ARENTMir advances a broad agenda on behalf of people with nontuberculous mycobacterial (NTM) disease, as well as healthcare providers, researchers….Read MoreSUPPORT GROUPSWhether it’s a local support group, online forums where you can exchange ideas with other patients, or links to other useful resources, you’ve come to the right place.Read More"INSIGHT" PATIENT PAMPHLETPrint or download our informative “Insight” pamphlet in multiple languages and keep the knowledge you need at your fingertips.Read MorePHYSICIAN REFERRAL LISTFind experts in the care you need with our Physician Referral List.Read MoreWHAT CAUSES PAP ?The three main causes of PAP are autoimmune, congenital,and secondary. Over ninety percent of people with PAP have the autoimmune form.Read More DONATEWe are supported by patients’ actions and donations, industry, and others who care about those with NTM lung disease.Read More Our MissionNTMir’s mission is to save and improve lives through research, education, early detection, and improved treatments for people with pulmonary nontuberculous mycobacterial infection (NTM disease).0Estimated cases of NTM in the US in 20200.2 %The rise in the number of NTM cases each year0.8 millionAntibiotic-resistant infections in the US each yearOur SponsorStay InformedSign up for NTMir's news releasesWHAT IS NTM?“NTM” is short for Nontuberculous Mycobacteria. NTM disease is a serious chronic lung illness.Learn MoreFacebook FeedNTM Info & ResearchOUR ADDRESS14411 S. Dixie Hwy ,Suite 205 ,Palmetto Bay,FL 33176Call Us: 305-901-4686 (ext 126, or 132)FOLLOW US COPYRIGHT © NTM INFO & RESEARCH, INC. ALL RIGHTS RESERVED. PRIVACY POLICY .sfsi_subscribe_Popinner { width: 100% !important; height: auto !important; padding: 18px 0px !important; background-color: #ffffff !important; } .sfsi_subscribe_Popinner form { margin: 0 20px !important; } .sfsi_subscribe_Popinner h5 { font-family: Helvetica,Arial,sans-serif !important; font-weight: bold !important; color: #000000 !important; font-size: 16px !important; text-align: center !important; margin: 0 0 10px !important; padding: 0 !important; } .sfsi_subscription_form_field { margin: 5px 0 !important; width: 100% !important; display: inline-flex; display: -webkit-inline-flex; } .sfsi_subscription_form_field input { width: 100% !important; padding: 10px 0px !important; } .sfsi_subscribe_Popinner input[type=email] { font-family: Helvetica,Arial,sans-serif !important; font-style: normal !important; color: !important; font-size: 14px !important; text-align: center !important; } .sfsi_subscribe_Popinner input[type=email]::-webkit-input-placeholder { font-family: Helvetica,Arial,sans-serif !important; font-style: normal !important; color: !important; font-size: 14px !important; text-align: center !important; } .sfsi_subscribe_Popinner input[type=email]:-moz-placeholder { /* Firefox 18- */ font-family: Helvetica,Arial,sans-serif !important; font-style: normal !important; color: !important; font-size: 14px !important; text-align: center !important; } .sfsi_subscribe_Popinner input[type=email]::-moz-placeholder { /* Firefox 19+ */ font-family: Helvetica,Arial,sans-serif !important; font-style: normal !important; color: !important; font-size: 14px !important; text-align: center !important; } .sfsi_subscribe_Popinner input[type=email]:-ms-input-placeholder { font-family: Helvetica,Arial,sans-serif !important; font-style: normal !important; color: !important; font-size: 14px !important; text-align: center !important; } .sfsi_subscribe_Popinner input[type=submit] { font-family: Helvetica,Arial,sans-serif !important; font-weight: bold !important; color: #000000 !important; font-size: 16px !important; text-align: center !important; background-color: #dedede !important; } .sfsi_shortcode_container { float: left; } .sfsi_shortcode_container .norm_row .sfsi_wDiv { position: relative !important; } .sfsi_shortcode_container .sfsi_holders { display: none; } English Deutsch (German) 日本語 (Japanese)#rev_slider_4_1_wrapper .hesperiden.tp-bullets{}#rev_slider_4_1_wrapper .hesperiden.tp-bullets:before{content:' ';position:absolute;width:100%;height:100%;background:transparent;padding:10px;margin-left:-10px;margin-top:-10px;box-sizing:content-box; border-radius:8px}#rev_slider_4_1_wrapper .hesperiden .tp-bullet{width:12px;height:12px;position:absolute;background:#999999; background:-moz-linear-gradient(top,#999999 0%,#e1e1e1 100%); background:-webkit-linear-gradient(top,#999999 0%,#e1e1e1 100%); background:-o-linear-gradient(top,#999999 0%,#e1e1e1 100%); background:-ms-linear-gradient(top,#999999 0%,#e1e1e1 100%); background:linear-gradient(to bottom,#999999 0%,#e1e1e1 100%); filter:progid:dximagetransform.microsoft.gradient( startcolorstr='#999999',endcolorstr='#e1e1e1',gradienttype=0 ); border:3px solid #e5e5e5;border-radius:50%;cursor:pointer;box-sizing:content-box}#rev_slider_4_1_wrapper .hesperiden .tp-bullet.rs-touchhover,#rev_slider_4_1_wrapper .hesperiden .tp-bullet.selected{background:#666666}#rev_slider_4_1_wrapper .hesperiden .tp-bullet-image{}#rev_slider_4_1_wrapper .hesperiden .tp-bullet-title{}